Literature DB >> 17426484

Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats.

Samira S Valvassori1, Benício N Frey, Márcio R Martins, Gislaine Z Réus, Filipe Schimidtz, Cecília G Inácio, Flávio Kapczinski, João Quevedo.   

Abstract

An increasing debate exists about the potential of early exposure to methylphenidate to increase the risk for drug abuse. In addition, little is known about the neurobiological effects of early exposure to methylphenidate. This study was designed to investigate whether chronic treatment with methylphenidate induces behavioral sensitization to subsequent methylphenidate and D-amphetamine challenge in adolescent Wistar rats. Young Wistar rats (P25) were treated with either methylphenidate (1, 2, or 10 mg/kg, intraperitoneally) or saline for 28 days. After 14 days of washout, animals were challenged with methylphenidate 2.5 mg/kg intraperitoneally or D-amphetamine 2 mg/kg intraperitoneally (P67). Locomotor behavior was assessed using the open field test. Rats chronically treated with methylphenidate in the adolescent period showed augmented locomotor sensitization to D-amphetamine but not to methylphenidate in the adult phase. These findings suggest that early exposure do methylphenidate might increase the risk for subsequent D-amphetamine abuse. Further studies focusing on the neurobiological effects of early exposure to methylphenidate are warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17426484     DOI: 10.1097/FBP.0b013e328153daf5

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  13 in total

1.  Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).

Authors:  Mircea I Chelaru; Pamela B Yang; Nachum Dafny
Journal:  Behav Brain Res       Date:  2011-08-25       Impact factor: 3.332

2.  Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.

Authors:  Erin S Calipari; Sara R Jones
Journal:  Neuropharmacology       Date:  2014-03-13       Impact factor: 5.250

3.  The effects of adolescent methylphenidate self-administration on responding for a conditioned reward, amphetamine-induced locomotor activity, and neuronal activation.

Authors:  Christie L Burton; José N Nobrega; Paul J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

4.  The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood.

Authors:  Seth C Harty; Iliyan Ivanov; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-08-08       Impact factor: 2.576

5.  The discriminative stimulus properties of methylphenidate in C57BL/6J mice.

Authors:  Robin W McGovern; Lawrence D Middaugh; Kennerly S Patrick; William C Griffin
Journal:  Behav Pharmacol       Date:  2011-02       Impact factor: 2.293

6.  Effect of Chronic Methylphenidate Treatment in a Female Experimental Model of Parkinsonism.

Authors:  Hannah V Oakes; David McWethy; Shannon Ketchem; Lily Tran; Kaitlyn Phillips; Laura Oakley; Richard J Smeyne; Brooks B Pond
Journal:  Neurotox Res       Date:  2021-03-05       Impact factor: 3.911

7.  Inhibition of mitochondrial respiratory chain in the brain of adult rats after acute and chronic administration of methylphenidate.

Authors:  Ana O Fagundes; Giselli Scaini; Patricia M Santos; Monique U Sachet; Nayara M Bernhardt; Gislaine T Rezin; Samira S Valvassori; Patrícia F Schuck; João Quevedo; Emilio L Streck
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

8.  Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.

Authors:  Brooke S G Molina; Stephen P Hinshaw; L Eugene Arnold; James M Swanson; William E Pelham; Lily Hechtman; Betsy Hoza; Jeffery N Epstein; Timothy Wigal; Howard B Abikoff; Laurence L Greenhill; Peter S Jensen; Karen C Wells; Benedetto Vitiello; Robert D Gibbons; Andrea Howard; Patricia R Houck; Kwan Hur; Bo Lu; Sue Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

9.  Methylphenidate treatment increases Na(+), K (+)-ATPase activity in the cerebrum of young and adult rats.

Authors:  Emilene B S Scherer; Cristiane Matté; Andréa G K Ferreira; Karin M Gomes; Clarissa M Comim; Cristiane Mattos; João Quevedo; Emilio L Streck; Angela T S Wyse
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

10.  Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine.

Authors:  Bethany R Brookshire; Sara R Jones
Journal:  Synapse       Date:  2012-06-13       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.